AGNC Investment Corp.'s preferred share AGNCN has been upgraded from overpriced to hold as its price declined closer to the buy range. AGNCN offers an attractive stripped yield of about 9.15% and a low risk rating of 2 out of 5, with a strong floating spread of 5.111%. However, it trades above its $25 call value, resulting in negative yield to call and elevated call risk, preventing a buy recommendation. The share is being closely monitored for further price drops that could make it a buy without fundamental changes.
AGNC Investment Corp.'s preferred share AGNCN offers a stripped yield of about 9.15%, nearing a buy range as of the latest market update. For readers following US Financials-sector stocks, here is Pluang's market snapshot as of Sep 15, 2026 03:21 WIB: out of 74 priced stocks, 30 rose and 44 fell. Notable movers include Deutsche Bank AG (DB) at USD 39.34 with a 1-day change of -2.82%, Aon PLC (AON) at USD 311.08 up 2.77%, and Affirm Holdings Inc (AFRM) at USD 73.21 up 2.48%.
Zatatep Tours, a licensed Tanzanian tour operator, has started accepting bitcoin alongside credit cards for booking safaris, treks, and beach stays in Tanzania. This move aims to simplify international payments by avoiding wire fees and currency conv...
BlackRock's Bitcoin ETF (IBIT) clients purchased $69.85 million worth of Bitcoin, continuing a trend of strong institutional demand. This buying follows a nine-day inflow streak where US spot Bitcoin ETFs attracted about $3 billion, the largest since...
A trader identified as 0x13da has opened a 5x leveraged long position in Solana (SOL) worth about $19.78 million, holding 164,642 SOL tokens with a liquidation price set at $99.68. This trader has a notable track record with a 78% win rate on previou...
Strategy reported an estimated $20.91 billion gain on its Bitcoin holdings in Q3 2026 due to revaluation at market prices, increasing the balance sheet value to $70.82 billion from an acquisition cost of $63.95 billion. Despite this accounting gain, ...
Intuitive Surgical continues to dominate the robotic surgery market with a strong competitive moat and promising growth prospects driven by high recurring revenues and expanding installed base. Despite some valuation multiple compression, its forward...
